Analyzing Pharmacodynamic Count Data That Rapidly Decrease to Zero
Open Access
- 4 December 2025
- journal article
- Published by Wiley in CPT: Pharmacometrics & Systems Pharmacology
- Vol. 15 (1)
Abstract
We present a framework for maximum likelihood analysis on count observations that begin high and quickly drop to zero, for example, from hollow fiber drug comparison studies. This simulation study focuses on treating observed counts as Poisson or normally distributed for the purpose of estimating infection rebound after effective treatment. CFU profiles were simulated from inoculation to 96 h post‐treatment. The PK‐PD link was an Emax inhibitory model. Random parameters were pathogen growth and natural decay rates, drug concentration for half‐maximal effect, and drug pathogen kill rate. Other parameters, including PK, were fixed. Parameters were adjusted to attain 67% efficacy at 24 h. Random parameter values were optimized for profiles observed at 24, 48, 72, and 96 h assuming each of four probability assumptions: (1) all CFU measurements were Poisson distributed (truth); (2) CFU < 128 were Poisson, higher values were normally distributed; (3) all observations were normally distributed; and (4) observations were normally distributed but CFU < 10 were censored. CFU‐time profiles were re‐simulated using the optimized parameter densities. Rebound percentage (CFU ≥ 10 at 24 h post‐treatment) was best predicted using strategy 2, above. For limited periodically collected time series count data that quickly fall to 0, the true proportion reaching 0 (lack of rebound) was best modeled by assuming Poisson distribution at low counts. At higher counts (≥ 128), assuming normality is reasonable. Censoring observations leads to biased models.Keywords
This publication has 15 references indexed in Scilit:
- An Overview of Modern Applications of Negative Binomial Modelling in Ecology and BiodiversityDiversity, 2022
- An Algorithm for Nonparametric Estimation of a Multivariate Mixing Distribution with Applications to Population PharmacokineticsPharmaceutics, 2020
- Nonparametric Methods in Population PharmacokineticsThe Journal of Clinical Pharmacology, 2020
- The Combination of Fosfomycin plus Meropenem Is Synergistic for Pseudomonas aeruginosa PAO1 in a Hollow-Fiber Infection ModelAntimicrobial Agents and Chemotherapy, 2018
- Estimation method for serial dilution experimentsJournal of Microbiological Methods, 2014
- Modeling and Simulation of Count DataCPT: Pharmacometrics & Systems Pharmacology, 2014
- Accurate Detection of Outliers and Subpopulations With Pmetrics, a Nonparametric and Parametric Pharmacometric Modeling and Simulation Package for RTherapeutic Drug Monitoring, 2012
- Evaluation of Mixture Modeling with Count Data Using NONMEMJournal of Pharmacokinetics and Pharmacodynamics, 2003
- Ways to Fit a PK Model with Some Data Below the Quantification LimitJournal of Pharmacokinetics and Pharmacodynamics, 2001
- Computer Generation of Poisson Deviates from Modified Normal DistributionsACM Transactions on Mathematical Software, 1982